171 related articles for article (PubMed ID: 36335815)
1. scBPGRN: Integrating single-cell multi-omics data to construct gene regulatory networks based on BP neural network.
Xuan C; Wang Y; Zhang B; Wu H; Ding T; Gao J
Comput Biol Med; 2022 Dec; 151(Pt A):106249. PubMed ID: 36335815
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatics analysis of the interactions among lncRNA, miRNA and mRNA expression, genetic mutations and epigenetic modifications in hepatocellular carcinoma.
Lin C; Yuan G; Hu Z; Zeng Y; Qiu X; Yu H; He S
Mol Med Rep; 2019 Feb; 19(2):1356-1364. PubMed ID: 30535497
[TBL] [Abstract][Full Text] [Related]
3. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.
Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W
J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391
[TBL] [Abstract][Full Text] [Related]
4. Construction of a ceRNA network and a genomic-clinicopathologic nomogram to predict survival for HBV-related HCC.
Huang K; Lu Z; Li L; Peng G; Zhou W; Ye Q
Hum Cell; 2021 Nov; 34(6):1830-1842. PubMed ID: 34487338
[TBL] [Abstract][Full Text] [Related]
5. Identification of Potentially Functional CircRNA-miRNA-mRNA Regulatory Network in Hepatocellular Carcinoma by Integrated Microarray Analysis.
Lin X; Chen Y
Med Sci Monit Basic Res; 2018 Apr; 24():70-78. PubMed ID: 29706616
[TBL] [Abstract][Full Text] [Related]
6. [Gene regulatory network of hepatocellular carcinoma: a review].
Liu X; Lian B; Lin Y
Sheng Wu Gong Cheng Xue Bao; 2016 Oct; 32(10):1322-1331. PubMed ID: 29027443
[TBL] [Abstract][Full Text] [Related]
7. Identification of Potential Diagnostic and Prognostic Pseudogenes in Hepatocellular Carcinoma Based on Pseudogene-miRNA-mRNA Competitive Network.
Yan L; Yue C; Xu Y; Jiang X; Zhang L; Wu J
Med Sci Monit; 2020 May; 26():e921895. PubMed ID: 32457285
[TBL] [Abstract][Full Text] [Related]
8. Construction of a disease-specific lncRNA-miRNA-mRNA regulatory network reveals potential regulatory axes and prognostic biomarkers for hepatocellular carcinoma.
Zhang Q; Sun L; Zhang Q; Zhang W; Tian W; Liu M; Wang Y
Cancer Med; 2020 Dec; 9(24):9219-9235. PubMed ID: 33232580
[TBL] [Abstract][Full Text] [Related]
9. Identification of Hypoxia-Related Prognostic Signature and Competing Endogenous RNA Regulatory Axes in Hepatocellular Carcinoma.
Tang Y; Zhang H; Chen L; Zhang T; Xu N; Huang Z
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362375
[TBL] [Abstract][Full Text] [Related]
10. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
[TBL] [Abstract][Full Text] [Related]
11. Screening Prognosis-Related lncRNAs Based on WGCNA to Establish a New Risk Score for Predicting Prognosis in Patients with Hepatocellular Carcinoma.
Zhou X; Dou M; Liu Z; Jiao D; Li Z; Chen J; Li J; Yao Y; Li L; Li Y; Han X
J Immunol Res; 2021; 2021():5518908. PubMed ID: 34426790
[TBL] [Abstract][Full Text] [Related]
12. Integrated Analysis of an lncRNA-Associated ceRNA Network Reveals Potential Biomarkers for Hepatocellular Carcinoma.
Yang J; Xu QC; Wang ZY; Lu X; Pan LK; Wu J; Wang C
J Comput Biol; 2021 Mar; 28(3):330-344. PubMed ID: 33185458
[No Abstract] [Full Text] [Related]
13. Bidirectional deep neural networks to integrate RNA and DNA data for predicting outcome for patients with hepatocellular carcinoma.
Huang G; Wang C; Fu X
Future Oncol; 2021 Nov; 17(33):4481-4495. PubMed ID: 34374301
[TBL] [Abstract][Full Text] [Related]
14. Gene expression, regulation of DEN and HBx induced HCC mice models and comparisons of tumor, para-tumor and normal tissues.
Tang Q; Wang Q; Zhang Q; Lin SY; Zhu Y; Yang X; Guo AY
BMC Cancer; 2017 Dec; 17(1):862. PubMed ID: 29254483
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analyses of competing endogenous RNA networks reveal potential biomarkers for predicting hepatocellular carcinoma recurrence.
Yan P; Huang Z; Mou T; Luo Y; Liu Y; Zhou B; Cao Z; Wu Z
BMC Cancer; 2021 Apr; 21(1):436. PubMed ID: 33879119
[TBL] [Abstract][Full Text] [Related]
16. Integrated multi-omics analysis of the clinical relevance and potential regulatory mechanisms of splicing factors in hepatocellular carcinoma.
Zhao YJ; Wu LY; Pang JS; Liao W; Chen YJ; He Y; Yang H
Bioengineered; 2021 Dec; 12(1):3978-3992. PubMed ID: 34288818
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of pathogenesis in hepatocellular carcinoma revealed by RNA‑sequencing.
Liu Y; Yang Z; Du F; Yang Q; Hou J; Yan X; Geng Y; Zhao Y; Wang H
Mol Med Rep; 2017 Nov; 16(5):6674-6682. PubMed ID: 28901494
[TBL] [Abstract][Full Text] [Related]
18. Constructing an integrated genetic and epigenetic cellular network for whole cellular mechanism using high-throughput next-generation sequencing data.
Chen BS; Li CW
BMC Syst Biol; 2016 Feb; 10():18. PubMed ID: 26897165
[TBL] [Abstract][Full Text] [Related]
19. Investigating the mechanism of hepatocellular carcinoma progression by constructing genetic and epigenetic networks using NGS data identification and big database mining method.
Li CW; Chang PY; Chen BS
Oncotarget; 2016 Nov; 7(48):79453-79473. PubMed ID: 27821810
[TBL] [Abstract][Full Text] [Related]
20. Multi-omics data identified TP53 and LRP1B as key regulatory gene related to immune phenotypes via EPCAM in HCC.
Shi L; Cao J; Lei X; Shi Y; Wu L
Cancer Med; 2022 May; 11(10):2145-2158. PubMed ID: 35150083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]